Dexcom (NSDQ:DXCM) said that it completed the sale of $850 million of 0.75% convertible senior notes due 2023. The San Diego, Calif.-based company expects to reel in roughly $836 million in net proceeds from the offering. Get the full story at our sister site, Drug Delivery Business News.
6 exhibitors at DeviceTalks West you should know
DeviceTalks West is an annual event that allows some of the best minds in medtech to exchange ideas, insights and technologies. Medical Design & Outsourcing’s parent company WTWH Media holds DeviceTalks annually in Boston, Orange County, Calif., and the Twin Cities in Minnesota. It is hosted by MassDevice and attendees can plan to enjoy networking with people in […]
Dexcom readies $750m debt offering
Dexcom (NSDQ:DXCM) said yesterday that it plans to offer $750 million in convertible senior notes due 2023 in a private placement to institutional buyers. The San Diego, Calif.-based company also expects to give buyers a 13-day option to buy up to an additional $100 million aggregate principal amount of notes. Get the full story at our […]
Dexcom inks $250m amended deal with Verily for next-gen diabetes tech
Dexcom (NSDQ:DXCM) said yesterday that it plans to pay $250 million upfront in stock to Verily in an amended collaboration and licensing deal. The two companies are working to develop a second-generation continuous glucose monitoring system. The updated deal also notes that the companies could collaborate on additional products and software. Get the full story at our sister […]
Dartmouth-Hitchcock hospitals to deploy Philips’ tele-ICU program
Dartmouth-Hitchcock Health (Lebanon, N.H.) has agreed to implement Royal Philips’ (NYSE: PHG) eICU program technology. The program aims to help reduce mortality, length of stay, and ventilation days while providing care to patients wherever they are located. Philips’ eICU is a tele-ICU program that will link specialists at the health system’s flagship hospital, Dartmouth-Hitchcock Medical Center […]
ivWatch inks distro deal for IV monitoring device
ivWatch said this week that it landed an international partner to manage the distribution of its continuous intravenous monitoring device. The Hampton, Va.-based company inked a deal with supplier New Medical to distribute its ivWatch Model 400 system in Australia and New Zealand. Get the full story at our sister site, Drug Delivery Business News.
Dexcom raises outlook after Q3 results top Wall Street estimates
Dexcom (NSDQ:DXCM) raised its full-year outlook yesterday after the medical device maker topped expectations on Wall Street with its third-quarter financial results. The San Diego, Calif.-based company posted profits of $46.6 million, or 53¢ per share, on sales of $266.7 million for the 3 months ended Sept. 30, for sales growth of 44% compared with the […]
Blue Spark wins CE Mark for wearable, wireless TempTraq monitor
Medtech developer Blue Spark Technologies said today it won CE Mark approval in the European Union for the TempTraq bluetooth wearable temperature monitor. The TempTraq system is a disposable, wearable continuous temperature monitoring patch that wirelessly delivers temperature readings, the Cleveland-based company said. The system includes the ability to set alerts, which are sent to […]
Apple Watch study enrolls 400k participants
An atrial fibrillation screening study using Apple‘s (NSDQ:AAPL) next-gen Apple Watch has enrolled 400,000 subjects, making it the largest study of its kind to date. Enrollment for the Apple Heart trial has been completed by Stanford University’s School of Medicine, and the study rationale and design has already been published in the American Heart Journal. […]
Prevent Biometrics acquires X2 Biosystems head impact monitoring assets
Head impact monitoring tech developer Prevent Biometrics said last week it acquired the head impact monitoring assets of Seattle-based X2 Biosystems for an undisclosed amount. Minneapolis-based Prevent Biometrics, which spun-out of the Cleveland Clinic in 2015, said that the acquisition will bring together its own Impact Monitor Mouthguard and X2’s skin patch-based platform. Prevent Biometrics […]
Philips wins FDA nod for IntelliVue GuardianSoftware mobile app
Royal Philips (NYSE:PHG) said today it won FDA 510(k) clearance for its IntelliVue GuardianSoftware mobile client application, designed to allow clinicians to view patient vital signs and receive early warning scores on mobile devices. The Amsterdam-based company said that the system is intended to move information that would normally be manually recorded in hospital medical-surgical units […]
- 1
- 2
- 3
- …
- 49
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube